mirvetuximab
immunogen
['mirvetuximab', 'gyn']
catching up on #gyncsm pd session - remarkable to see progress we are making from targeted therapies - especially adcs. farthest along is mirvetuximab soravtansine in pts w high folate receptor alpha expression which has been submitted for accelerated approval! #asco22
Breast & gyn med onc @valleyhospital in NJ. Focus on survivorship and ?????? onc. All opinions my own. Retweets not endorsements. Host of INTERLUDE podcast ??